Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self
The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
Naturally arising CD25(+)CD4(+) regulatory T cells actively maintain immunological self-tolerance. Deficiency in or dysfunction of these cells can be a cause of autoimmune disease. A reduction in their number or function can also elicit tumor immunity, whereas their antigen-specific population expansion can establish transplantation tolerance. They are therefore a good target for designing ways to induce or abrogate immunological tolerance to self and non-self antigens.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growing evidence has shown that Treg cells are recruited into the TME and behave as powerful immunosuppressors.61, 62”
From Reactive Oxygen Species in Cancer: Current Findings and Future Directions (2021) · cites this paper as [62]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Self-citationFoxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745 · cited 1×
“In addition, they specifically express Foxp3 , which encodes a transcription factor, as a key control gene in their development and functio”
BackgroundPark, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Self-citationA CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Groux, H., O'Garra, A., Bigler, M., Rouleau, M., Antonenko, S., de Vries, J. E., & Roncarolo, M. G. (1997) · Nature · doi:10.1038/39614 · Cited by 3,588
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141122 · Cited by 3,306
Self-citationThe Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032 · cited 1×
“The fact that many tumor-associated antigens recognized by autologous T cells in cancer patients are antigenically normal self constituents indicates that natural CD25 + CD4 + T reg cells engaged in the maintenance of self-tolerance may concomitantly impede immunosurveillance against autologous tumor cell”
BackgroundTivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Research works printed but not linked: 1
- Setoguchi, R., Hori, S., Takahashi, T. & Sakaguchi, S. A crucial role of IL-2 in the homeostatic maintenance of CD25+CD4+ regulatory T cells: induction of autoimmune disease by neutralization of IL-2. J. Exp. Med. (in the press).
Cited by
Items 801–900 of 1,010
Immunomodulation of NK Cells by Ionizing Radiation
Chen, J., Liu, X., Zeng, Z., Li, J., Luo, Y. M., Sun, W., Gong, Y. Q., Zhang, J., Wu, Q., & Xie, C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00874 · Cited by 65
“Regulatory T Cells (Tregs) Tregs are observed to maintain immune tolerance and hinder suppression of infections and cancers by inhibiting effector T cells, B cells and NK cells (59, 60).”
BackgroundBeyersdorf, N., Hanke, T., Kerkau, T., & Hünig, T. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.06.001 · Cited by 66
Treg control of antimicrobial T cell responses
Suvas, S., & Rouse, B. T. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.03.005 · Cited by 61
Ukena, S. N., Hoepting, M., Velaga, S., Ivanyi, P., Grosse, J., Baron, U., Ganser, A., & Franzke, A. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.08.010 · Cited by 64
Jeffery, H. C., Braitch, M. K., Brown, S., & Oo, Y. H. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00334 · Cited by 70
Debnath, M. (2015) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-015-9626-9 · Cited by 62
Ocklenburg, F., Moharregh-Khiabani, D., Geffers, R., Janke, V., Pfoertner, S., Garritsen, H., Groebe, L., Klempnauer, J., Dittmar, K. E. J., Weiß, S., et al. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700432 · Cited by 60
Paus, R., Schröder, J. ‐., Reich, K., Kabashima, K., Liu, F. T., Romani, N., Metz, M., Kerstan, A., Lee, P. H. A., Loser, K., et al. (2006) · Experimental Dermatology · doi:10.1111/j.1600-0625.2006.00506_1.x · Cited by 73
Succinate drives gut inflammation by promoting FOXP3 degradation through a molecular switch
Wang, H., Hu, D., Cheng, Y., Gao, Q., Liu, K., Mani, N. L., Tang, A. Y., Iyer, R., Gao, B., Sun, L., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02166-y · Cited by 59
RANKL/RANK – From bone physiology to breast cancer
Sigl, V., & Penninger, J. M. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.01.002 · Cited by 64
Jadidi‐Niaragh, F., Yousefi, M., Memarian, A., Hojjat‐Farsangi, M., Khoshnoodi, J., Razavi, S. M., Jeddi‐Tehrani, M., & Shokri, F. (2013) · Cancer Investigation · doi:10.3109/07357907.2012.756110 · Cited by 59
“(IL-7Rα) are also characteristic features of nTreg cells (10).”
BackgroundKarin, N., & Wildbaum, G. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00609 · Cited by 67
The role of helminth infections in protection from atopic disorders
Yazdanbakhsh, M., & Wahyuni, S. (2005) · Current Opinion in Allergy & Clinical Immunology · doi:10.1097/01.all.0000182541.52971.eb · Cited by 57
P38 MAP Kinase Signaling Is Required for the Conversion of CD4+CD25− T Cells into iTreg
Huber, S., Schrader, J., Fritz, G., Presser, K., Schmitt, S., Waisman, A., Lüth, S., Blessing, M., Herkel, J., & Schramm, C. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003302 · Cited by 65
“CD4+CD25+ Treg are crucial for the maintenance of peripheral immune tolerance and the prevention of chronic inflammation and autoimmune disease [1].”
BackgroundLimited Peripheral T Cell Anergy Predisposes to Retinal Autoimmunity
Lambe, T., Leung, J. C. H., Ferry, H., Bouriez-Jones, T., Makinen, K., Crockford, T. L., Jiang, H. R., Nickerson, J. M., Peltonen, L., Forrester, J. V., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4276 · Cited by 58
Sewgobind, V. D. K. D., Kho, M. M. L., van der Laan, L. J. W., Hendrikx, T. K., van Dam, T., Tilanus, H. W., IJzermans, J. N. M., Weimar, W., & Baan, C. C. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn778 · Cited by 59
“Thymus-derived natural immunoregulatory CD4+ T cells do not only have important activities in the prevention of autoimmunity [1,2] but also control immune responses towards transplanted organs and tissues [2,3].”
BackgroundLess Yin, More Yang: Confronting the Barriers to Cancer Immunotherapy
Lizee, G. A., Cantu, M. A., & Hwu, P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1722 · Cited by 61
Role of regulatory T-cells in H. pylori-induced gastritis and gastric cancer.
Kandulski, A., Malfertheiner, P., & Wex, T. (2010) · PubMed · Cited by 79
Jiang, D., Gao, Z., Cai, Z., Wang, M., & He, J. (2015) · BMC Cancer · doi:10.1186/s12885-015-1742-7 · Cited by 68
“FOXP3 has been considered the most specific marker for Treg cells [16, 17].”
BackgroundAlloantigen-induced regulatory CD8+CD103+ T cells
Koch, S. D., Uss, E., van Lier, R. A. W., & ten Berge, I. J. M. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.08.281 · Cited by 58
Transforming growth factor-β: Recent advances on its role in immune tolerance
Kriegel, M. A., Li, M. O., Sanjabi, S., Wan, Y. Y., & Flavell, R. A. (2006) · Current Rheumatology Reports · doi:10.1007/s11926-006-0054-y · Cited by 66
Vaccines against Human Carcinomas: Strategies to Improve Antitumor Immune Responses
Palena, C., & Schlom, J. (2010) · BioMed Research International · doi:10.1155/2010/380697 · Cited by 62
Kim, H., Keum, D., Kwak, J. W., Chung, H., & Bae, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114726 · Cited by 62
“Tregs also have various functions in the control of transplantation tolerance, tumor immunity, allergy, and infection [8, 9, 10].”
BackgroundCirculating IL-35 in pancreatic ductal adenocarcinoma patients
Jin, P., Ren, H., Sun, W., Xin, W., Zhang, H., & Hao, J. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.09.018 · Cited by 58
Human CD4 + HLA‐G + regulatory T cells are potent suppressors of graft‐versus‐host disease in vivo
Pankratz, S., Bittner, S., Herrmann, A. M., Schuhmann, M. K., Ruck, T., Meuth, S. G., & Wiendl, H. (2014) · The FASEB Journal · doi:10.1096/fj.14-251074 · Cited by 58
Zhao, Y., Lutalo, P., Thomas, J. E., Sangle, S. R., Choong, L., Tyler, J. R., Tree, T. I. M., Spencer, J., & D’Cruz, D. P. (2013) · Rheumatology · doi:10.1093/rheumatology/ket406 · Cited by 60
Kimpfler, S., Sevko, A., Ring, S., Falk, C. S., Osen, W., Frank, K., Kato, M., Mahnke, K., Schadendorf, D., & Umansky, V. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900609 · Cited by 69
“Treg are critical for the maintenance of self-tolerance and constitutively express CD25 (IL-2R ), glucocorticoid-induced TNF related protein (GITR), and CTLA-4 (8, 9).”
BackgroundMonastra, G., Grazia, S. D., Mıçılı, S. Ç., Göker, A., & Unfer, V. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1200556 · Cited by 60
“cells, and the dendritic cells maturation [151,152].”
Antioxidant and Ex Vivo Immune System Regulatory Properties of Boswellia serrata Extracts
Beghelli, D., Isani, G., Roncada, P., Andreani, G., Bistoni, O., Bertocchi, M., Lupidi, G., & Alunno, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7468064 · Cited by 58
“As reported in Figure 3(b), when cells were stimulated by PWM, a mitogen that stimulates B lymphocytes in the presence of T-cells, the PBMC proliferation was significantly increased (𝑝 0.05) by the addition of the BS extracts (0.1 𝜇g/mL for both extracts A and G) and the LPI did not change between the two BS extracts…”
BackgroundInfluentialNew insights to the immunopathology and autoimmune responses in primary biliary cirrhosis
He, X.-S., Ansari, A. A., Ridgway, W. M., Coppel, R. L., & Gershwin, M. E. (2006) · Cellular Immunology · doi:10.1016/j.cellimm.2006.04.006 · Cited by 59
PLAU inferred from a correlation network is critical for suppressor function of regulatory T cells
HeFeng, F. Q., Chen, H., Probst‐Kepper, M., Geffers, R., Eifes, S., del Sol, A., Schughart, K., Zeng, A., & Balling, R. (2012) · Molecular Systems Biology · doi:10.1038/msb.2012.56 · Cited by 66
CD28 superagonists: Mode of action and therapeutic potential
Hünig, T., & Dennehy, K. M. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.06.012 · Cited by 63
Rahimian, G., Sanei, M. H., Shirzad, H., Azadegan‐Dehkordi, F., Taghikhani, A., Salimzadeh, L., Chaleshtori, M. H., Rafieian‐Kopaei, M., & Bagheri, N. (2014) · Microbial Pathogenesis · doi:10.1016/j.micpath.2013.12.006 · Cited by 61
Ettinger, R. A., James, E. A., Kwok, W. W., Thompson, A. R., & Pratt, K. P. (2010) · Haemophilia · doi:10.1111/j.1365-2516.2008.01905.x · Cited by 57
“The CD4+CD25+ cell subset contains Tregs, which play a key role in the maintenance of peripheral tolerance [58].”
BackgroundKudo, D., Toyama, M., Aoyagi, T., Akahori, Y., Yamamoto, H., Ishii, K., Kanno, E., Maruyama, R., Kaku, M., Kushimoto, S., et al. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12106 · Cited by 59
“Regulatory T (Treg) cells are a subset of CD4 + T cells that express the surface marker CD25 and the transcription factor forkhead box protein 3 (FoxP3), and these Treg cells have been implicated in controlling autoreactive T cells in vivo [28] .”
BackgroundEffects of Natalizumab Treatment on Foxp3+ T Regulatory Cells
Stenner, M., Waschbisch, A., Buck, D., Doerck, S., Einsele, H., Toyka, K. V., & Wiendl, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003319 · Cited by 58
Zanin‐Zhorov, A., Lin, J., Scher, J. U., Kumari, S., Blair, D. A., Hippen, K. L., Blazar, B. R., Abramson, S. B., Lafaille, J. J., & Dustin, M. L. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110120109 · Cited by 60
“Foxp3 deficiency leads to defects in Treg function, which manifest as a multiorgan fatal inflammatory disease in mice (5, 6).”
Shaffer, J., Villard, J., Means, T. K., Alexander, S. I., Dombkowski, D., Dey, B. R., McAfee, S. L., Ballen, K. K., Saidman, S. L., Preffer, F. I., et al. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.03.018 · Cited by 57
“Our data demonstrate enrichment for regulatory T cells [38,39] early post-transplant in Protocols A, B and C, but not Protocol D.”
Weiss, E., Schmidt, A., Vobis, D., Garbi, N., Lahl, K., Mayer, C. T., Sparwasser, T. D., Ludwig, A., Suri‐Payer, E., Oberle, N., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002321 · Cited by 57
“Our data are in contrast to that of Banz et al. (42) who observed resistance of prestimulated murine CD4+CD25+T cells toward apoptosis triggered by CD95 stimulation in vitro.”
BackgroundInfluentialCD4+Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice
Weigert, O., von Spee-Mayer, C., Undeutsch, R., Kloke, L., Humrich, J. Y., & Riemekasten, G. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4188 · Cited by 60
“Regulatory T cells (Treg), expressing the transcription factor Foxp3, are crucial for the maintenance of peripheral self-tolerance [12-14].”
BackgroundSrivastava, R. K., Tomar, G. B., Barhanpurkar, A. P., Gupta, N., Pote, S. T., Mishra, G. C., & Wani, M. R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002691 · Cited by 57
“kine, and the exact source of IL-2 has been a matter of intense research in the last decade (9, 34).”
BackgroundFurcron, A.-E., Romero, R. J., Mial, T. N., Balancio, A., Panaitescu, B., Hassan, S. S., Sahi, A., Nord, C., & Gomez‐Lopez, N. (2016) · Biology of Reproduction · doi:10.1095/biolreprod.116.139345 · Cited by 57
MicroRNA-146a induces immune suppression and drug-resistant colorectal cancer cells
Khorrami, S., Hosseini, A. Z., Mowla, S. J., Soleimani, M., Rakhshani, N., & Malekzadeh, R. (2017) · Tumor Biology · doi:10.1177/1010428317698365 · Cited by 58
Scrivo, R., Massaro, L., Barbati, C., Vomero, M., Ceccarelli, F., Spinelli, F. R., Riccieri, V., Spagnoli, A., Alessandri, C., Desideri, G., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0184449 · Cited by 65
Ali, S., Majid, S., Ali, M. N., Taing, S., Rehman, M. U., & Arafah, A. M. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107118 · Cited by 62
New aspects of the molecular basis of contact allergy
Cavani, A., Pità, O. D., & Girolomoni, G. (2007) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3282ef6923 · Cited by 57
Interference with immune‐cell‐mediated bone resorption in periodontal disease
Han, X., Kawai, T., & Taubman, M. A. (2007) · Periodontology 2000 · doi:10.1111/j.1600-0757.2007.00215.x · Cited by 68
Targeting tumour-associated macrophages
Sica, A., Rubino, L., Mancino, A., Larghi, P., Porta, C., Rimoldi, M., Solinas, G., Locati, M., Allavena, P., & Mantovani, A. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.9.1219 · Cited by 67
“Suppression of T-cell-mediated antitumour activity by Treg cells is associated with increased tumour growth and, hence, decreased survival [40] .”
BackgroundCD4+CD25+ Regulatory T Cells and Graft-Versus-Host Disease
Hoffmann, P., & Edinger, M. (2006) · Seminars in Hematology · doi:10.1053/j.seminhematol.2005.09.006 · Cited by 64
Maeda, Y., Wada, H., Sugiyama, D., Saito, T., Irie, T., Itahashi, K., Minoura, K., Suzuki, S., Kojima, T., Kakimi, K., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27574-0 · Cited by 61
Interest of Tumor-Specific CD4 T Helper 1 Cells for Therapeutic Anticancer Vaccine
Galaine, J., Borg, C., Godet, Y., & Adotévi, O. (2015) · Vaccines · doi:10.3390/vaccines3030490 · Cited by 63
“for Th9, Th22 and follicular helper T cells [12–17].”
BackgroundLiu, Y., Wu, Y., Wang, Y., Cai, Y., Hu, B., Bao, G., Fang, H., Zhao, L., Ma, S., Cheng, Q., et al. (2014) · Leukemia · doi:10.1038/leu.2014.310 · Cited by 58
A naturally occurring CD8+CD122+ T-cell subset as a memory-like Treg family
Li, S., Xie, Q., Zeng, Y., Zou, C., Liu, X., Wu, S., Deng, H., Xu, Y., Li, X. C., & Dai, Z. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.25 · Cited by 62
Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris
Amber, K. T., Staropoli, P. C., Shiman, M. I., Elgart, G. W., & Hertl, M. (2013) · Experimental Dermatology · doi:10.1111/exd.12229 · Cited by 56
Wolf, A. M., Eller, K., Zeiser, R., Dürr, C., Gerlach, U. V., Sixt, M., Markut, L., Gastl, G. A., Rosenkranz, A. R., & Wolf, D. G. F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901011 · Cited by 59
“Treg play a decisive role in the maintenance of immunological tolerance (2).”
BackgroundGaardbo, J. C., Hartling, H. J., Gerstoft, J., & Nielsen, S. D. (2012) · AIDS Research and Treatment · doi:10.1155/2012/161584 · Cited by 56
Gao, W., Guo, Y., Wang, C., Lin, Y., Li, Y., Sheng, T., Wu, Z., & Yang, G. (2016) · Acta Histochemica · doi:10.1016/j.acthis.2016.06.004 · Cited by 56
Wang, Y., Zhou, C., Gao, H., Li, C., Li, D., Liu, P., Huang, M., Shen, X., & Liu, L. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.05.006 · Cited by 58
Overcoming the resistance of pancreatic cancer to immune checkpoint inhibitors
Skelton, R. A., Javed, A. A., Zheng, L., & He, J. P. (2017) · Journal of Surgical Oncology · doi:10.1002/jso.24642 · Cited by 63
“They have very high levels of FoxP3, a transcription factor that produces TGF-β that interferes with pro-inflammatory cytokine promoters (such as IL-2) and prevents their production.(24) Regulatory T-cells inhibit CD-4 and CD-8 T-cell proliferation and activation through CTLA-4 binding to B-7.”
BackgroundInfluentialStasikowska‐Kanicka, O., Wągrowska‐Danilewicz, M., & Danilewicz, M. (2017) · Pathology & Oncology Research · doi:10.1007/s12253-017-0270-y · Cited by 65
“self-antigens, the suppression of tumor antigen reactive T lymphocytes by Tregs is an important obstacle in antitumor immunity [13].”
BackgroundUmbilical cord blood cells for treatment of cerebral palsy; timing and treatment options
McDonald, C., Fahey, M. C., Jenkin, G., & Miller, S. (2017) · Pediatric Research · doi:10.1038/pr.2017.236 · Cited by 57
Fuchizawa, T., Adachi, Y., Ito, Y., Higashiyama, H., Kanegane, H., Futatani, T., Kobayashi, I., Kamachi, Y., Sakamoto, T., Tsuge, I., et al. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.08.004 · Cited by 56
Migration and function of FoxP3+ regulatory T cells in the hematolymphoid system
Kim, C. H. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.03.014 · Cited by 60
Regulatory T cells and Toll-like receptors in tumor immunity
Wang, R., Peng, G., & Wang, H. Y. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.01.008 · Cited by 59
Yun, J., Jialal, I., & Devaraj, S. (2010) · British Journal Of Nutrition · doi:10.1017/s000711451000005x · Cited by 72
Reduced Function of CD4+25+ Regulatory T Cell Fraction in Silicosis Patients
Wu, P., Miura, Y., Hyodoh, F., Nishimura, Y., Hatayama, T., Hatada, S., Sakaguchi, H., Kusaka, M., Katsuyama, H., Tomita, M., et al. (2006) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200601900212 · Cited by 56
Ryan, K. R., Patel, S. D., Stephens, L. A., & Anderton, S. M. (2007) · Journal of Autoimmunity · doi:10.1016/j.jaut.2007.07.014 · Cited by 56
“Although these cells come in various guises, depending on the precise experimental approach, the population that has come to the fore in recent years are the so-called ‘‘natural’’ CD4þ CD25þ Treg cells that express the forkhead box P3 (Foxp3) transcription factor [18].”
BackgroundAn Open Question: Is It Rational to Inhibit the mTor-Dependent Pathway as COVID-19 Therapy?
Terrazzano, G., Rubino, V., Palatucci, A. T., Giovazzino, A., Carriero, F., & Ruggiero, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00856 · Cited by 57
“…response regulation, of great relevance is the role of regulatory T cells (Tregs), which are a subpopulation of CD4+ T lymphocytes involved in the control of immunological self-tolerance and in the maintenance of immune homeostasis (Sakaguchi, 2005; Strauss et al., 2007; Procaccini et al., 2010).”
BackgroundThe Peripheral Immune System and Traumatic Brain Injury: Insight into the role of T-helper cells
Bao, W., Lin, Y., & Chen, Z. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.46834 · Cited by 59
“IL-6, transforming growth factor (TGF)-β, and IL-1β are vital factors in Th17 cell development [33] while IL-2 is responsible for Treg cell development [34].”
BackgroundTawara, I., Shlomchik, W. D., Jones, A., Zou, W., Nieves, E. C., Liu, C., Toubai, T., Duran‐Struuck, R., Sun, Y., Clouthier, S. G., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001625 · Cited by 61
“Foxp3 (8, 9), These so-called “natural” regulatory T cells (Tregs) develop in the thymus.”
BackgroundKatsuki, M., Hirooka, Y., Kishi, T., & Sunagawa, K. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000469 · Cited by 59
“In contrast, regulatory T (Treg) cells, an immunosuppressive T-cell lineage identified most specifically by Foxp3 expression [14], protect against blood pressure elevation and target organ damage induced by Ang II [15,16].”
BackgroundZhang, R., Tian, A., Zhang, H., Zhou, Z., Yu, H., & Chen, L. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9483-1 · Cited by 61
“Antiinflammatory regulatory T cells have been found to be an important CD4 cell subpopulation for controlling the development of autoimmune disease (Fernandez-Martin et al. 2006; Sakaguchi 2005; Reddy et al. 2004; Viglietta et al. 2004).”
BackgroundHomeostatic regulation of T effector to Treg ratios in an area of seasonal malaria transmission
Finney, O. C., Nwakanma, D. C., Conway, D. J., Walther, M., & Riley, E. M. (2009) · European Journal of Immunology · doi:10.1002/eji.200839112 · Cited by 57
Xing, Q., Su, H., Cui, J., & Wang, B. (2011) · Immunological Investigations · doi:10.3109/08820139.2011.578189 · Cited by 55
“It has been shown that only those cells expressing high levels of CD25 (CD25high) efficiently suppress proliferative responses, thus being considered true regulatory T cells (Sakaguchi, 2005).”
BackgroundPekiner, F. N., Aytuğar, E., Demirel, G. Y., & Borahan, M. O. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01061.x · Cited by 55
Lai, X., Pei, Q., Song, X., Zhou, X., Yin, Z., Jia, R., Zou, Y., Li, L., Yue, G., Liang, X., et al. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.01.028 · Cited by 59
Ng, M. S. F., Roth, T. L., Mendoza, V. F., Marson, A., & Burt, T. D. (2019) · Science Immunology · doi:10.1126/sciimmunol.aav5947 · Cited by 57
Metabolic regulation on the immune environment of glioma through gut microbiota
Lyu, Y., Yang, H., & Liang, C. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.005 · Cited by 58
Microbial Manipulation of Immune Function for Asthma Prevention: Inferences from Clinical Trials
Yoo, J., Tcheurekdjian, H., Lynch, S. V., Cabana, M., & Boushey, H. A. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200702-033aw · Cited by 54
“New methods for enumerating and assessing Treg number and activity (73) would reveal whether acceleration of development of this apparently critical cell population might be responsible for accelerating the maturation from an infantile Th2-biased pattern of immune responsiveness to a mature, balanced pattern of respon…”
MethodMathematical modeling of allergy and specific immunotherapy: Th1–Th2–Treg interactions
Groß, F., Metzner, G., & Behn, U. (2010) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2010.10.013 · Cited by 61
Pathogenesis of cutaneous lupus erythematosus
Kuhn, A., & Bijl, M. (2008) · Lupus · doi:10.1177/0961203308090019 · Cited by 55
Inhibition of the allergic response by regulatory T cells
Stock, P., DeKruyff, R. H., & Umetsu, D. T. (2006) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/01.all.0000200502.69672.44 · Cited by 55
Yang, X. (2007) · Frontiers in bioscience · doi:10.2741/2775 · Cited by 56
“(50), CD3+CD4-CD8-αβTCR+ T cells (53) have been reported, among which CD4+CD25 Tregs are the best characterized (11, 38, 39, 54, 55).”
BackgroundLou, W., Wang, C., Wang, Y., Han, D., & Zhang, L. (2011) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2011.01249.x · Cited by 61
“Although previous studies have suggested an increase in Treg cell response in asthmatic children receiving pollen- or HDM-SIT, as indicated by an increase in CD4CD25 T cells (12, 20), recent evidence suggests that CD25 is an activation marker of T lymphocytes and not a specific marker of Treg cells (21).”
ResultGlatigny, S., Duhen, R., Arbelaez, C., Kumari, S., & Bettelli, E. (2015) · Scientific Reports · doi:10.1038/srep07834 · Cited by 51
Uterine Regulatory T cells, IL‐10 and Hypertension
Nevers, T., Kalkunte, S. S., & Sharma, S. (2011) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2011.01040.x · Cited by 54
Regulation of FoxP 3+ Regulatory T Cells and Th17 Cells by Retinoids
Kim, C. H. (2008) · Clinical and Developmental Immunology · doi:10.1155/2008/416910 · Cited by 62
“[7] S.”
BackgroundThe role of virus-induced regulatory T cells in immunopathology
Robertson, S. J., & Hasenkrug, K. J. (2006) · Springer Seminars in Immunopathology · doi:10.1007/s00281-006-0019-2 · Cited by 62
Nunzio, S. D., Cecconi, M., Passerini, L., McMurchy, A. N., Baron, U., Türbachova, I., Vignola, S., Valencic, E., Tommasini, A., Junker, A., et al. (2009) · Blood · doi:10.1182/blood-2009-04-214593 · Cited by 54
Regulatory T cells prevent plaque disruption in apolipoprotein E-knockout mice
Meng, X., Li, W., Yang, J., Zhang, K., Qin, W., An, G., Gao, F., Wang, Y., Zhang, C., & Zhang, Y. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.03.026 · Cited by 54
Liu, T., Dai, W., Li, C. R., Liu, F., Chen, Y., Weng, D., & Chen, J. (2015) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00868 · Cited by 56
Trichinella-induced immunomodulation: Another tale of helminth success
Bruschi, F., Ashour, D. S., & Othman, A. A. (2022) · Food and Waterborne Parasitology · doi:10.1016/j.fawpar.2022.e00164 · Cited by 58
“These cells have been characterized by constitutive expression of surface CD4 and CD25 (IL-2 receptor α chain) and by the expression of Foxp3 (Sakaguchi, 2005).”
BackgroundThe biologic importance of tumor‐infiltrating lymphocytes
Hodi, F. S., & Dranoff, G. (2010) · Journal of Cutaneous Pathology · doi:10.1111/j.1600-0560.2010.01506.x · Cited by 57
Regulatory T cells protect against hypoxia-induced pulmonary arterial hypertension in mice
Chu, Y., XiangLi, X., & Xiao, W. L. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.3106 · Cited by 53
Wong, T.-H., Chen, H.-A., Gau, R., Yen, J., & Suen, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168919 · Cited by 58
The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit?
Jiang, T., Li, G., Xu, J., Gao, S., & Xu, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02047 · Cited by 58
“On the other hand, the abnormal proliferation of both types of Tregs leads to the failure of self-/non-self-discrimination, resulting in autoimmune disease (49).”
BackgroundRegulatory T cells mediated immunomodulation during asthma: a therapeutic standpoint
Khan, M. A. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02632-1 · Cited by 63
Functional Dynamics of Naturally Occurring Regulatory T Cells in Health and Autoimmunity
Levings, M. K., Allan, S., d'Hennezel, E. B., & Piccirillo, C. A. (2006) · Advances in immunology · doi:10.1016/s0065-2776(06)92003-3 · Cited by 60
Influencing the fates of CD4 T cells on the path to memory: lessons from influenza
Jelley‐Gibbs, D. M., Strutt, T. M., McKinstry, K. K., & Swain, S. L. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.13 · Cited by 67
Chattopadhyay, S., Mehrotra, S., Chhabra, A., Hegde, U. P., Mukherji, B., & Chakraborty, N. G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.2.984 · Cited by 57
“When taken in this overall context, our data beg the question of how relevant and central nTregs act physiologically when an immune response is called for in the defense against infectious agents or transplantation Ags or when the generation of an antitumor T cell response is deliberately attempted with the full force…”
Influential
Metadata
- Authors
- Sakaguchi, S.
- Affiliations
- Kyoto University (JP)
- Corresponding author
- Sakaguchi, Shimon
- ORCID
- Sakaguchi, Shimon
- Venue
- Nature Immunology
- Published
- 2005-03-22
- Volume
- 6
- Issue
- 4
- Pages
- 345-352
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- OpenAlex
- W2004708987
- Cited by
- 2,669
- References
- 109
- Citations by year
- 2026: 12 · 2025: 33 · 2024: 39 · 2023: 54 · 2022: 59 · 2021: 68 · 2020: 68 · 2019: 84 · 2018: 83 · 2017: 92 · 2016: 98 · 2015: 113 · 2014: 127 · 2013: 148 · 2012: 169
- FWCI
- 22.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- Foxp3, regulatory T cells, CD4+CD25+ T cells, immune tolerance, self-tolerance, autoimmune disease, antitumor immunity, transplantation tolerance, antigen-specific T cell expansion, immunomodulation
- MeSH terms
- Animals, Antigens, Differentiation, Autoimmune Diseases, DNA-Binding Proteins, Humans, Lymphocyte Activation, Neoplasms, T-Lymphocytes, Thymus Gland, Transplantation Immunology, Receptors, Interleukin-2, Antigens, CD, CD4 Antigens, Self Tolerance, Forkhead Transcription Factors, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.